A Cell Mediated Immune Response Assay With Enhanced Sensitivity

Patent No. EP2726883 (titled "A Cell Mediated Immune Response Assay With Enhanced Sensitivity") was filed by Cellestis on Jun 27, 2012. The application was issued on May 18, 2022.

Patent Summary

UPC Cases New

Latest UPC cases involving this patent.

Case NumberFiling DatePlaintiffProceeding Type
UPC_CFI_516/2025Jun 10, 2025Biomerieux, Biomerieux DeutschlandCounter Claim For Revocation
UPC_CFI_497/2025Jun 10, 2025Biomerieux DeutschlandCounter Claim For Revocation
UPC_CFI_181/2025Feb 28, 2025Qiagen SciencesInfringement

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BIOMERIEUXDec 27, 2018CABINET BEAU DE LOMENIE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2726883

CELLESTIS
Application Number
EP12804281A
Filing Date
Jun 27, 2012
Status
Patent Maintained As Amended
Apr 15, 2022
Publication Date
May 18, 2022